QSAR, HQSAR and GRIND Studies on a Set of Heterocyclic Propafenone-Type Inhibitors of P-Glycoprotein
1
Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
2
Department of Drug and Natural Product Synthesis, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 201; https://doi.org/10.3797/scipharm.oephg.21.PO-02
Submission received: 16 April 2009
/
Accepted: 16 April 2009
/
Published: 16 April 2009
Abstract
P-Glycoprotein (P-gp) is a member of the ABC (ATP binding cassette) super-family of transport proteins, which in addition to their physiological role in tissue protection, actively extrude a large variety of therapeutically administered drugs from the malignant cells and thus are responsible for multiple drug resistance (MDR) in cancer patients [1]. Since the discovery of P-gp more than 30 years ago many studies have shown that MDR can be reversed by the use of inhibitors, often denoted as MDR modulators.
Share and Cite
MDPI and ACS Style
JABEEN, I.; PLAGENS, B.; HOLZER, W.; ECKER, G.F. QSAR, HQSAR and GRIND Studies on a Set of Heterocyclic Propafenone-Type Inhibitors of P-Glycoprotein. Sci. Pharm. 2009, 77, 201. https://doi.org/10.3797/scipharm.oephg.21.PO-02
AMA Style
JABEEN I, PLAGENS B, HOLZER W, ECKER GF. QSAR, HQSAR and GRIND Studies on a Set of Heterocyclic Propafenone-Type Inhibitors of P-Glycoprotein. Scientia Pharmaceutica. 2009; 77(Posters (PO)):201. https://doi.org/10.3797/scipharm.oephg.21.PO-02
Chicago/Turabian StyleJABEEN, I., B. PLAGENS, W. HOLZER, and G. F. ECKER. 2009. "QSAR, HQSAR and GRIND Studies on a Set of Heterocyclic Propafenone-Type Inhibitors of P-Glycoprotein" Scientia Pharmaceutica 77, Posters (PO): 201. https://doi.org/10.3797/scipharm.oephg.21.PO-02
